drugset / Trial / NCT00280618
Oxaliplatin in Unresectable Hepatocellular Carcinoma
RandomizedParallel-groupOpen-labelTreatment
Summary
Primary: * To determine the Tumor Response Rate of patients with hepatocellular carcinoma treated with the combination chemotherapy of Eloxatin+5-Fluorouracil/Leucovorin Secondary: * Safety and tolerability of this regimen in these patients
Timeline
- Start
- 2004-07
- Primary completion
- 2006-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxaliplatin | Small molecule | — | — |